Year: 1992 Source: Drugs, v.43, suppl.2, (1992), p.48-54 SIEC No: 19920717

A review of the safety & tolerability of fluvoxamine in worldwide marketing studies involving 24,624 patients, predominantly receiving fluvoxamine teatment in uncontrolled studies, was conducted. Results show that the overall incidence of serious adverse events associated with this treatment was 2.5%, & the incidence of overall suicidality, including suicidal ideation, overdose, & intentional overdose as well as attempted & completed acts of suicide, was remarkably low at 0.8%.